Medicines360

Analysis

Medicines360 is a registered charity in United States, based in San Francisco, CA. It received its IRS tax-exemption ruling in May 2009, 17 years ago. Its declared purposes cover medical research, which this site groups under health and saving lives. The IRS classifies it as a hospital or medical research organisation under section 501(c)(3), and contributions to it are listed as tax-deductible.

In the financial year ending December 2023, Medicines360 reported income of $10.0m and spending of $19.3m, spending 193% of what it took in. Across the 5 years on record, from December 2019 to December 2023, income fell from $17.4m to $10.0m (-42%), an average of -13% a year. The sharpest change came in the year to December 2021, when income rose by 105%. Over the whole period it spent 144% of the income it received.

Among 40,470 United States charities whose main cause is health and saving lives and that reported income, Medicines360 sits at the 84th percentile: it is larger than about 84% of them. Against every charity in United States with reported income it ranks in the 95th percentile, and in the 95th percentile within CA. Charities of a similar size with the same main cause include American Epilepsy Society ($10.0m), Carmelite Sisters of the Divine Heart of Jesus of Ind ($10.0m) and Rhode Island Quality Institute ($10.0m).

On its Form 990 for the period ending December 2023, revenue came from contributions and grants 8.5% of the total. Compensation of current officers, directors and key employees was $3.0m (16% of expenses). Other salaries and wages came to $6.0m. At year end it held assets of $52.0m against liabilities of $5.2m, net assets of $46.8m. It reported 46 employees.